IgA nephropathy: an interesting autoimmune kidney disease

A Rajasekaran, BA Julian, DV Rizk - The American journal of the medical …, 2021 - Elsevier
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide. It is a leading cause of chronic kidney disease and progresses to end-stage …

IgA nephropathy

JC Rodrigues, M Haas, HN Reich - Clinical Journal of the …, 2017 - journals.lww.com
IgA nephropathy (IgAN) is a leading cause of CKD and renal failure. Recent international
collaborative efforts have led to important discoveries that have improved our understanding …

Current treatment of IgA nephropathy

J Floege, T Rauen, SCW Tang - Seminars in immunopathology, 2021 - Springer
IgA nephropathy (IgAN) is the most common type of glomerulonephritis in Asia and the
Western world. In most patients, it follows an asymptomatic to oligosymptomatic course and …

Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies

J Xia, L Wang, Z Ma, L Zhong, Y Wang… - Nephrology Dialysis …, 2017 - academic.oup.com
Background. Cigarette smoking has been established as a major risk factor for chronic
kidney disease (CKD) development in people with diabetes. Conflicting evidence exists …

New strategies and perspectives on managing IgA nephropathy

H Selvaskandan, CK Cheung, M Muto… - Clinical and experimental …, 2019 - Springer
IgA nephropathy is an inflammatory renal disease characterised by the deposition of IgA in
the glomerular mesangium and is the most commonly reported primary glomerulonephritis …

High neutrophil-to-lymphocyte ratio is an independent risk factor for end stage renal diseases in IgA nephropathy

S Wang, L Dong, G Pei, Z Jiang, A Qin, J Tan… - Frontiers in …, 2021 - frontiersin.org
Background Complex factors are involved in the development and progression of
immunoglobulin A nephropathy (IgAN), a common primary glomerulonephritis worldwide …

Treatment of IgA nephropathy and Henoch–Schönlein nephritis

J Floege, J Feehally - Nature Reviews Nephrology, 2013 - nature.com
Abstract Treatment options for primary IgA nephropathy (IgAN) and Henoch–Schönlein
nephritis are still largely based on opinion or weak evidence. Consequently, the recent …

Platelet-to-albumin ratio: a novel IgA nephropathy prognosis predictor

J Tan, G Song, S Wang, L Dong, X Liu, Z Jiang… - Frontiers in …, 2022 - frontiersin.org
Background Chronic inflammation is related to the development of IgA nephropathy (IgAN).
Emerging studies have reported that platelet-related parameters including platelet (PLT) …

Evidence-based clinical practice guidelines for IgA nephropathy 2014

Y Yuzawa, R Yamamoto, K Takahashi… - Clinical and …, 2016 - Springer
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common primary
glomerulonephritis, and patients typically require dialysis when the disease progresses to …

Efficacy of aerobic exercise on the cardiometabolic and renal outcomes in patients with chronic kidney disease: a systematic review of randomized controlled trials

R Yamamoto, T Ito, Y Nagasawa, K Matsui… - Journal of …, 2021 - Springer
Background Several randomized controlled trials (RCTs) have demonstrated the
cardiometabolic effects of aerobic exercise in the general population and in patients with …